1-(5'-hydroxyhexyl)-3,7-dimethylxanthine,
1-(5R-hydroxyhexyl)-3,7-dimethylxanthine,
3,7-dimethyl-1-(5-hydroxyhexyl)xanthine,
A-802710,
BL 194,
CT-1501R,
lisofylline,
(+/-)-Lisofylline,
6493-06-7,
Hydroxy pentoxifylline,
Lisofylline [USAN:INN],
BL 194,
1-((R)-5-Hydroxyhexyl)theobromine,
(+/-)-1-(5-Hydroxyhexyl)-3,7-dimethylxanthine,
1-(5'-Hydroxyhexyl)-3,7-dimethylxanthine,
NSMXQKNUPPXBRG-UHFFFAOYSA-N,
(R)-Lisophylline,
C13H20N4O3,
NCGC00163298-01,
3,7-Dimethyl-1-(5-hydroxyhexyl)xanthine,
1-(5R-Hydroxyhexyl)-3,7-dimethylxanthine,
CT 1501R,
1-(5-Hydroxyhexyl)-3,7-dimethyl-3,7-dihydro-1H-purine-2,6-dione,
Xanthine, 1-(5'-hydroxyhexyl)-3,7-dimethyl,
DSSTox_CID_26343,
DSSTox_RID_81547,
DSSTox_GSID_46343,
UNII-L1F2Q2X956,
1-(5-hydroxyhexyl)-3,7-dimethyl-1H-purine-2,6(3H,7H)-dione,
1H-Purine-2,6-dione, 3,7-dihydro-1-(5-hydroxyhexyl)-3,7-dimethyl-,
1H-Purine-2,6-dione, 3,7-dihydro-1-(5-hydroxyhexyl)-3,7-dimethyl-, (R)-,
CAS-6493-06-7,
lysofylline,
L1F2Q2X956,
UNII-R99EE080JS,
Penthydroxyfylline,
R99EE080JS,
Pentoxifylline Alcohol,
5-Hydroxy pentoxifylline,
AC1L1NOB,
Penthydroxyfylline alcohol,
Lisofylline, (+/-)-,
SCHEMBL680306,
1-(5-Hydroxyhexyl)theobromine,
CHEMBL1514176,
DTXSID6046343,
CTK8F1540,
CHEBI:143565,
Theobromine, 1-(5-hydroxyhexyl)-,
LSF,
Tox21_112043,
1055AH,
BL-194,
MFCD00871850,
Tox21_112043_1,
API0000069,
(+/-)-Lisofylline, analytical standard,
SMP2_000274,
NCGC00163298-02,
1-(5-hydroxyhexyl)-3,7-dimethylxanthine,
LS-171741,
LS-176415,
FT-0670823,
1-(5-hydroxyhexyl)-3,7-dimethylpurine-2,6-dione,
3,7-Dihydro-1-(5-hydroxyhexyl)-3,7-dimethyl-1H-purine-2,6-dione,
1-(5'-Hydroxyhexyl)-3,7-dimethylxanthine/ LSF/ BL 194/ CT-1501R/ 5-Hydroxy pentoxifylline,
LISOFYLLINE,
ProTec,
Lisophylline,
(R)-Lisofylline,
CT-1501R,
CID57782,
1-[(R)-5-hydroxyhexyl]theobromine,
C13-H20-N4-O3,
CS-O-05856,
A-802710,
100324-81-0,
3,7-Dihydro-1-[(5R)-5-hydroxyhexyl]-3,7-dimethyl-1H-purine-2,6-dione,